Picture: 123RF/KENG PO LEUNG
Picture: 123RF/KENG PO LEUNG

Steven Schultz from Momentum chose Adcock Ingram as his stock pick of the day.

“My stock is Adcock Ingram, well known for Panado, it currently has about 65% of its revenue from prescriptions and over-the-counter meds and around 25% from hospital drug usage. It’s significantly derated this year and went down around 29% over the past 12 months.”

Would you like to comment on this article or view other readers' comments?
Register (it’s quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.